Those Accounts match the data submitted by the companies to the FDA’s Vaccines and Related Biological Products Advisory Committee, Which reviews safety and efficacy. According to briefing documents, the Pfizer formula caused fatigue in 59.4 percent of trial participants after their second dose, headaches in 51.7 percent, muscle pain in 37.3 percent, joint pain in 21.9 percent, chills in 35.1 percent and headaches in 15.8 percent. The numbers for the Moderna formula, which were released Tuesday, are similar: Fatigue in 68.5 percent of recipients, Headache in 63 percent, aches and pains in 59.6 percent, chills in 43.4 percent and fever in 15.6 percent.